Atuveciclib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAtuveciclib
Drug Alias Nameatuveciclibum奥妥西利BAY-1143572
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene proteinCyclin-dependent kinase 9
Therapy Area/IndicationsLeukemiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeTaiwan +[5] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsLeukemiaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A